Lataa...
Disease-modifying therapy for proteinopathies: Can the exception become the rule?
Disease-modifying therapies for proteinopathies are urgently needed yet clinical trials for the major neurodegenerative diseases, Alzheimer’s and Parkinson’s, have been failing at an alarming rate leaving patients and caregivers scrambling for any sign of hope. At the same time, for one family of pr...
Tallennettuna:
| Julkaisussa: | Prog Mol Biol Transl Sci |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032046/ https://ncbi.nlm.nih.gov/pubmed/31699321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/bs.pmbts.2019.07.010 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|